303 related articles for article (PubMed ID: 36077094)
1. Ceramide Acyl Chain Length and Its Relevance to Intracellular Lipid Regulation.
Ho QWC; Zheng X; Ali Y
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077094
[TBL] [Abstract][Full Text] [Related]
2. Contribution of specific ceramides to obesity-associated metabolic diseases.
Hammerschmidt P; Brüning JC
Cell Mol Life Sci; 2022 Jul; 79(8):395. PubMed ID: 35789435
[TBL] [Abstract][Full Text] [Related]
3. The role of ceramides in metabolic disorders: when size and localization matters.
Turpin-Nolan SM; Brüning JC
Nat Rev Endocrinol; 2020 Apr; 16(4):224-233. PubMed ID: 32060415
[TBL] [Abstract][Full Text] [Related]
4. Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases.
Raichur S
Front Endocrinol (Lausanne); 2020; 11():483. PubMed ID: 32849276
[TBL] [Abstract][Full Text] [Related]
5. The effect of altered sphingolipid acyl chain length on various disease models.
Park WJ; Park JW
Biol Chem; 2015 Jun; 396(6-7):693-705. PubMed ID: 25720066
[TBL] [Abstract][Full Text] [Related]
6. Ceramide synthases as potential targets for therapeutic intervention in human diseases.
Park JW; Park WJ; Futerman AH
Biochim Biophys Acta; 2014 May; 1841(5):671-81. PubMed ID: 24021978
[TBL] [Abstract][Full Text] [Related]
7. Different rates of flux through the biosynthetic pathway for long-chain versus very-long-chain sphingolipids.
Zelnik ID; Volpert G; Viiri LE; Kauhanen D; Arazi T; Aalto-Setälä K; Laaksonen R; Futerman AH
J Lipid Res; 2020 Oct; 61(10):1341-1346. PubMed ID: 32651186
[TBL] [Abstract][Full Text] [Related]
8. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
9. N-Palmitoyl Serinol Stimulates Ceramide Production through a CB1-Dependent Mechanism in In Vitro Model of Skin Inflammation.
Shin KO; Kim S; Park BD; Uchida Y; Park K
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361066
[TBL] [Abstract][Full Text] [Related]
10. Ceramides - Lipotoxic Inducers of Metabolic Disorders.
Chaurasia B; Summers SA
Trends Endocrinol Metab; 2015 Oct; 26(10):538-550. PubMed ID: 26412155
[TBL] [Abstract][Full Text] [Related]
11. Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin.
Farwanah H; Raith K; Neubert RH; Wohlrab J
Arch Dermatol Res; 2005 May; 296(11):514-21. PubMed ID: 15803327
[TBL] [Abstract][Full Text] [Related]
12. Ceramides and skin function.
Coderch L; López O; de la Maza A; Parra JL
Am J Clin Dermatol; 2003; 4(2):107-29. PubMed ID: 12553851
[TBL] [Abstract][Full Text] [Related]
13. Fuse your mitochondria, lose appetite: an anorexic, anti-obesity sphingolipid.
Muley C; Bartelt A
EMBO Mol Med; 2021 Aug; 13(8):e14618. PubMed ID: 34288516
[TBL] [Abstract][Full Text] [Related]
14. Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes.
Bellini L; Campana M; Mahfouz R; Carlier A; Véret J; Magnan C; Hajduch E; Le Stunff H
Expert Opin Ther Targets; 2015; 19(8):1037-50. PubMed ID: 25814122
[TBL] [Abstract][Full Text] [Related]
15. The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease.
Nicholson RJ; Norris MK; Poss AM; Holland WL; Summers SA
Annu Rev Nutr; 2022 Aug; 42():115-144. PubMed ID: 35584813
[TBL] [Abstract][Full Text] [Related]
16. Eleven residues determine the acyl chain specificity of ceramide synthases.
Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
Kihara A
Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
[TBL] [Abstract][Full Text] [Related]
18. Ceramides in Metabolism: Key Lipotoxic Players.
Chaurasia B; Summers SA
Annu Rev Physiol; 2021 Feb; 83():303-330. PubMed ID: 33158378
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid metabolism in organotypic mouse keratinocyte cultures.
Madison KC; Swartzendruber DC; Wertz PW; Downing DT
J Invest Dermatol; 1990 Dec; 95(6):657-64. PubMed ID: 2123494
[TBL] [Abstract][Full Text] [Related]
20. Ceramides and mitochondrial fatty acid oxidation in obesity.
Fucho R; Casals N; Serra D; Herrero L
FASEB J; 2017 Apr; 31(4):1263-1272. PubMed ID: 28003342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
